COMMUNIQUÉS West-GlobeNewswire

Avicanna Announces Pre-Clinical Data Supporting Enhanced Absorption and Patent Filing for Novel Oral Delivery Platform
19/11/2025
PwdRx novel drug delivery platform demonstrated superior bioavailability and accelerated absorption of cannabinoids in preclinical studies Provisional patent application on the novel drug delivery platform which can be [...]
Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption
19/11/2025
RESEARCH TRIANGLE PARK, N.C., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced it has repurchased and [...]
LUKE and Asset Health Forge National Partnership to Advance Human Flourishing for America’s Heroes
19/11/2025
ROCKLEDGE, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- LUKE Holdings, Inc. (“LUKE”), a trusted leader in healthcare staffing for the United States Government, today announced a strategic partnership with Asset Health, a [...]
Johns Hopkins Health Plans Announces New VP of Medicare Advantage
19/11/2025
Lori Rund Brings Industry Experience, Strategic Expertise and Innovative Leadership HANOVER, Md., Nov. 19, 2025 (GLOBE NEWSWIRE) -- On Nov. 3, Lori Rund joined Johns Hopkins Health Plans as Vice President of Medicare [...]
Spryte Medical Receives FDA IDE Approval to Initiate “INSYTE” US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment
19/11/2025
BEDFORD, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spryte Medical, a pioneer in intravascular neuro imaging, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug [...]
HealthEx appoints Jeremy Schwarz as Chief Commercial Officer
19/11/2025
SAN FRANCISCO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- HealthEx , a modern data rights management platform that enables individuals to securely access and share their health records for personal use or with any trusted third [...]
Cellution Biologics Inc. Announces U.S. Launch of AmnioPlast 1 and AmnioPlast Double for Ocular Surface Repair
19/11/2025
ROSWELL, Ga., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cellution Biologics Inc., today announced the introduction of AmnioPlast 1™ ( Dehydrated Monolayered Human Amnion Membrane Allograft) and AmnioPlast Double™ (Dehydrated, [...]
USOSM Partner Practices Accredited by AAAHC, Recognized as Oral and Maxillofacial Centers of Excellence
19/11/2025
IRVING, Texas, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The Accreditation Association for Ambulatory Health Care ( AAAHC ) has accredited two additional U.S. Oral Surgery Management ( USOSM ) partner practices. They are North [...]
RespireRx Pharmaceuticals Inc. Announces NIH/NINDS Grant Award and Amended and Restated Patent License Agreement
19/11/2025
Glen Rock, N.J., Nov. 19, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases [...]
Nxera Introduces Employee Stock Ownership Plan (J-ESOP) for Employees Residing in Japan
19/11/2025
Tokyo, Japan and Cambridge, UK, 19 November 2025 – Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) announces that its Board of Directors have decided to replace the current Restricted Share Unit (“RSU”) Plan [...]
BioPorto Interim Result for the Third Quarter of 2025 – Continued progress and continued NGAL sales growth
19/11/2025
November 19, 2025 Announcement no. 26 BioPorto Interim Result for the Third Quarter of 2025 – Continued progress and continued NGAL sales growth. Copenhagen, Denmark, November 19, 2025, (GLOBE NEWSWIRE) – BioPorto A/S [...]
Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical
19/11/2025
Aptose Biosciences minority shareholders to receive C$2.41 in cash per share in a “go private” transaction SAN DIEGO and TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) ( [...]
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma
19/11/2025
Lunsumio provides high rates of deep and long-lasting responses in third-line and later follicular lymphoma, a disease that typically becomes harder to treat each time a patient relapses 1,2 Lunsumio subcutaneous offers [...]
Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
18/11/2025
SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025
18/11/2025
NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced it will [...]
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
18/11/2025
Renowned urologist Dr. Mark Hong sets new global benchmark for urologist-led, MRI-guided prostate treatment, leading a growing movement toward incision-free prostate therapy TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- [...]
SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025
18/11/2025
SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the [...]
BBOT to Participate in Upcoming December Investor Healthcare Conferences
18/11/2025
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today [...]
Solana Company Reports Third Quarter 2025 Financial Results
18/11/2025
NEWTOWN, Pa., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury (“DAT”) dedicated to [...]

Pages